Clinical predictors of decline in nutritional parameters over time in ESRD

Clinical Journal of the American Society of Nephrology

Volumn 9, Issue 2, 2014, Pages 318-325

  den Hoedt, Claire H ^a,b   Bots, Michiel L ^b   Grooteman, Muriel P C ^c   van der Weerd, Neelke C ^d   Penne, E Lars ^c   Mazairac, Albert H A ^b   Levesque, Renée ^e   Blankestijn, Peter J ^b   Nubé, Menso J ^c   ter Wee, Piet M ^c   van den Dorpel, Marinus A ^a  

^a Maasstad Hospital Rotterdam   (Netherlands)

^b UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d ACADEMIC MEDICAL CENTER   (Netherlands)

^e UNIVERSITY OF MONTREAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AGE FACTORS; AGED; BIOLOGICAL MARKERS; BODY MASS INDEX; C-REACTIVE PROTEIN; FEMALE; HEMODIAFILTRATION; HUMANS; INFLAMMATION MEDIATORS; INTERLEUKIN-6; KIDNEY FAILURE, CHRONIC; LINEAR MODELS; MALE; MALNUTRITION; MIDDLE AGED; NUTRITION ASSESSMENT; NUTRITIONAL STATUS; RENAL DIALYSIS; RISK FACTORS; SERUM ALBUMIN; SEX FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84893574716     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.04470413     Document Type: Article

References (26)

1. Tripepi G, Mallamaci F, Zoccali C: Inflammation markers, adhesion molecules, and all-cause and cardiovascular mortality in patients with ESRD: Searching for the best risk marker by multivariatemodeling. J AmSoc Nephrol 16[Suppl 1]: S83-S88, 2005
2. Carrero JJ, Stenvinkel P: Inflammation in end-stage renal disease-what have we learned in 10 years? Semin Dial 23: 498-509, 2010
3. Kalantar-Zadeh K, Ikizler TA, Block G, Avram MM, Kopple JD: Malnutrition-inflammation complex syndrome in dialysis patients: Causes and consequences. Am J Kidney Dis 42: 864-881, 2003
4. Mazairac AH, de Wit GA, Grooteman MP, Penne EL, van der Weerd NC, van den Dorpel MA, Nubé MJ, Lévesque R, TerWee PM, Bots ML, Blankestijn PJ; CONTRAST investigators: A composite score of protein-energy nutritional status predicts mortality in haemodialysis patients no better than its individual components. Nephrol Dial Transplant 26: 1962-1967, 2011
5. Zoccali C, Tripepi G, Mallamaci F: Dissecting inflammation in ESRD: Do cytokines and C-reactive protein have a complementary prognostic value for mortality in dialysis patients? J AmSoc Nephrol 17[Suppl 3]: S169-S173, 2006
6. Rocco MV, Dwyer JT, Larive B, Greene T, Cockram DB, Chumlea WC, Kusek JW, Leung J, Burrowes JD, McLeroy SL, Poole D, Uhlin L; HEMO Study Group: The effect of dialysis dose and membrane flux on nutritional parameters in hemodialysis patients: Results of the HEMO Study. Kidney Int 65: 2321-2334, 2004
7. Bossola M, La Torre G, Giungi S, Tazza L, Vulpio C, Luciani G: Serum albumin, body weight and inflammatory parameters in chronic hemodialysis patients: A three-year longitudinal study. Am J Nephrol 28: 405-412, 2008
8. Beberashvili I, Sinuani I, Azar A, Yasur H, Shapiro G, Feldman L, Averbukh Z, Weissgarten J: IL-6 levels, nutritional status, and mortality in prevalent hemodialysis patients. Clin J Am Soc Nephrol 6: 2253-2263, 2011
9. Meuwese CL, Snaedal S, Halbesma N, Stenvinkel P, Dekker FW, Qureshi AR, Barany P, Heimburger O, Lindholm B, Krediet RT, Boeschoten EW, Carrero JJ: Trimestral variations of C-reactive protein, interleukin-6 and tumour necrosis factor-a are similarly associated with survival in haemodialysis patients. Nephrol Dial Transplant 26: 1313-1318, 2011
10. Atesx K, Atesx A, Ekmekçi Y, Nergizoglu G: The time course of serum C-reactive protein is more predictive of mortality than its baseline level in peritoneal dialysis patients. Perit Dial Int 25: 256-268, 2005
11. Snaedal S, Heimbürger O, Qureshi AR, Danielsson A, Wikström B, Fellström B, Fehrman-Ekholm I, Carrero JJ, Alvestrand A, Stenvinkel P, Bárány P: Comorbidity and acute clinical events as determinants of C-reactive protein variation in hemodialysis patients: Implications for patient survival. Am J Kidney Dis 53: 1024-1033, 2009
12. Kaysen GA, Dubin JA, Müller HG, Rosales LM, Levin NW; The HEMO Study Group: The acute-phase response varies with time and predicts serum albumin levels in hemodialysis patients. Kidney Int 58: 346-352, 2000
13. Kaysen GA, Dubin JA, Müller HG, Rosales L, Levin NW, Mitch WE; HEMO Study Group NIDDK: Inflammation and reduced albumin synthesis associated with stable decline in serum albumin in hemodialysis patients. Kidney Int 65: 1408-1415, 2004
14. Leavey SF, Strawderman RL, Young EW, Saran R, Roys E, Agodoa LY, Wolfe RA, Port FK: Cross-sectional and longitudinal predictors of serum albumin in hemodialysis patients. Kidney Int 58: 2119-2128, 2000
15. Grooteman MP, van den Dorpel MA, Bots ML, Penne EL, van der Weerd NC, Mazairac AH, den Hoedt CH, van der Tweel I, Lévesque R, Nubé MJ, ter Wee PM, Blankestijn PJ; CONTRAST Investigators: Effect of online hemodiafiltration on all-cause mortality and cardiovascular outcomes. J Am Soc Nephrol 23: 1087-1096, 2012
16. Penne EL, Blankestijn PJ, Bots ML, van den Dorpel MA, Grooteman MP, Nubé MJ, van der Tweel I, Ter Wee PM; the CONTRAST study group: Effect of increased convective clearance by on-line hemodiafiltration on all cause and cardiovascular mortality in chronic hemodialysis patients-the Dutch CONvective TRAnsport STudy (CONTRAST): Rationale and design of a randomised controlled trial [ISRCTN38365125]. Curr Control Trials Cardiovasc Med 6: 8, 2005
17. Clase CM, St Pierre MW, Churchill DN: Conversion between bromcresol green-and bromcresol purple-measured albumin in renal disease. Nephrol Dial Transplant 16: 1925-1929, 2001
18. Jager KJ, MerkusMP, Huisman RM, Boeschoten EW, Dekker FW, Korevaar JC, Tijssen JG, Krediet RT; NECOSAD Study Group: Nutritional status over time in hemodialysis and peritoneal dialysis. J Am Soc Nephrol 12: 1272-1279, 2001
19. Schild AF, Perez E, Gillaspie E, Seaver C, Livingstone J, Thibonnier A: Arteriovenous fistulae vs. arteriovenous grafts: A retrospective review of 1,700 consecutive vascular access cases. J Vasc Access 9: 231-235, 2008
20. Akoh JA: Prosthetic arteriovenous grafts for hemodialysis. J Vasc Access 10: 137-147, 2009
21. RaoM, GuoD, Perianayagam MC, TighiouartH, Jaber BL, Pereira BJ, Balakrishnan VS: Plasma interleukin-6 predicts cardiovascular mortality in hemodialysis patients. Am J Kidney Dis 45: 324-333, 2005
22. Allon M, Radeva M, Bailey J, Beddhu S, Butterly D, Coyne DW, Depner TA, Gassman JJ, Kaufman AM, Kaysen GA, Lewis JA, Schwab SJ; HEMO Study Group: The spectrum of infectionrelated morbidity in hospitalized haemodialysis patients. Nephrol Dial Transplant 20: 1180-1186, 2005
23. Carrero JJ, Qureshi AR, Axelsson J, Avesani CM, Suliman ME, Kato S, Bárány P, Snaedal-Jonsdottir S, Alvestrand A, Heimbürger O, Lindholm B, Stenvinkel P: Comparison of nutritional and inflammatory markers in dialysis patients with reduced appetite. Am J Clin Nutr 85: 695-701, 2007
24. Stenvinkel P, Wanner C, Metzger T, Heimbürger O, Mallamaci F, Tripepi G, Malatino L, Zoccali C: Inflammation and outcome in end-stage renal failure: Does female gender constitute a survival advantage? Kidney Int 62: 1791-1798, 2002
25. Pupim LB, Heimbürger O, Qureshi AR, Ikizler TA, Stenvinkel P: Accelerated lean body mass loss in incident chronic dialysis patients with diabetes mellitus. Kidney Int 68: 2368-2374, 2005
26. Shafi T, Jaar BG, Plantinga LC, Fink NE, Sadler JH, Parekh RS, Powe NR, Coresh J: Association of residual urine output with mortality, quality of life, and inflammation in incident hemodialysis patients: The Choices for Healthy Outcomes in Caring for End-Stage Renal Disease (CHOICE) Study. Am J Kidney Dis 56: 348-358, 2010